Individualized hybrid breastfeeding education for first-time mothers

The Effect of Individualized Hybrid Breastfeeding Education in Late Pregnancy on Antenatal Attachment and Breastfeeding Behaviors in Primiparous Women

Not applicable Interventional Kahramanmaras Sutcu Imam University · NCT07478341

This program will try whether personalized face-to-face plus online breastfeeding education in late pregnancy helps first-time mothers bond with their baby and breastfeed successfully.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment64 (estimated)
Ages18 Years to 35 Years
SexFemale
SponsorKahramanmaras Sutcu Imam University Academic / other
Locations1 site (Elbistan, Kahramanmaraş)
Trial IDNCT07478341 on ClinicalTrials.gov

What this trial studies

This randomized controlled program delivers individualized breastfeeding education beginning at 36 weeks of pregnancy, with a face-to-face session, a reinforcement/practice session at 38 weeks, and personalized digital materials and short videos. Participants also receive online consultation support and postpartum follow-up sessions in the first week and at six weeks after birth. Outcomes include measures of antenatal maternal-fetal attachment and breastfeeding behaviors such as initiation and exclusivity. The control group receives routine hospital education while the intervention group receives the hybrid, personalized program.

Who should consider this trial

Good fit: First-time pregnant women aged 18–35 with a singleton pregnancy at or after 36 weeks who can read Turkish and have access to a smartphone or the internet are ideal candidates.

Not a fit: Women with pregnancy complications, multiple gestation, inability to attend the required sessions, or no internet/smartphone access are unlikely to benefit from this program.

Why it matters

Potential benefit: If successful, the program could strengthen maternal antenatal attachment and increase breastfeeding self-efficacy, leading to earlier initiation and higher rates of exclusive breastfeeding among first-time mothers.

How similar studies have performed: Prior educational and psychosocial prenatal interventions have improved breastfeeding initiation and self-efficacy, and hybrid face-to-face plus digital approaches have shown promising results in related research.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

Aged 18-35 years,

At 36 weeks of gestation or later,

Experiencing their first pregnancy (primiparous),

Having a singleton pregnancy,

Able to read and write in Turkish and capable of communication,

Having access to a smartphone or the internet,

Free from any physical or mental health problems that would prevent participation in the education,

Willing to voluntarily participate in the study and provide written informed consent.

Exclusion Criteria:

Presence of chronic physical illness or pregnancy complications (e.g., preeclampsia, gestational diabetes),

Multiple pregnancy,

Gestation earlier than 36 weeks,

Inability to actively participate in the education due to communication barriers or cognitive impairment,

Lack of access to a smartphone or the internet,

Failure to attend any stage of the educational program or voluntary withdrawal from the study,

Refusal to participate in the study or failure to sign the informed consent form.

Where this trial is running

Elbistan, Kahramanmaraş

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Breast FeedingExclusive Breast FeedingMaternal-Fetal AttachmentPrimiparityBreastfeeding EducationHybrid EducationPrimiparous WomenAntenatal Attachment
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.